Health and Fitness Health and Fitness
Wed, November 30, 2011
[ Wed, Nov 30th 2011 ] - Market Wire
Compugen Presents Predictive Drug Target Discovery Platform at European Antibody Conference
[ Wed, Nov 30th 2011 ] - Market Wire
Curis Announces Agreement with The Leukemia & Lym .. evelop CUDC-907 for Lymphoma and Multiple Myeloma
[ Wed, Nov 30th 2011 ] - Market Wire
Given Imaging Files Patent Infringement Lawsuit in Korea Against Intromedic
[ Wed, Nov 30th 2011 ] - Market Wire
FONAR Sells UPRIGHT Multi-Position MRI Scanner to .. hased Dynamic Weight-Bearing Multi-Position MRI T
[ Wed, Nov 30th 2011 ] - Market Wire
Omeros Announces It Has Unlocked Over 20 Percent of Class A Orphan GPCRs
[ Wed, Nov 30th 2011 ] - Market Wire
Soliris (culizumab) obtient une autorisation de m .. ur le traitement des patients atteints du syndrom
[ Wed, Nov 30th 2011 ] - Market Wire
Positive Clinical Study Results Reported by Adeona's Oral Zinc for ALS Collaborator
[ Wed, Nov 30th 2011 ] - Market Wire
Astex Pharmaceuticals to Present at World Epigenetics Summit on December 8th
[ Wed, Nov 30th 2011 ] - Market Wire
Watson Launches Generic LIPITOR
Tue, November 29, 2011
[ Tue, Nov 29th 2011 ] - Market Wire
Gilead ottiene dagli enti normativi europei compe .. ommercializzazione di Eviplera, un nuovo regime c
[ Tue, Nov 29th 2011 ] - Market Wire
Clovis Oncology Announces Exercise of Underwriter .. se 700,000 Shares of Clovis Oncology Common Stock
[ Tue, Nov 29th 2011 ] - Market Wire
Elan Provides an Update on ELND005 (Scyllo-inositol)
[ Tue, Nov 29th 2011 ] - Market Wire
St. Jude Medical Announces FDA Approval of Industryas First Quadripolar Pacing System
[ Tue, Nov 29th 2011 ] - Market Wire
NPS Pharmaceuticals to Present at Deutsche Bank BioFEST Conference
[ Tue, Nov 29th 2011 ] - Market Wire
Health Management Associates, Inc. to Present at .. a Merrill Lynch 2011 Leveraged Finance Conference
[ Tue, Nov 29th 2011 ] - Market Wire
BioMarin Initiates Phase 2 Study for GALNS in Patients Under Five Years of Age With MPS IVA
[ Tue, Nov 29th 2011 ] - Market Wire
Ceapro Reports Third Quarter 2011 Financial Results
[ Tue, Nov 29th 2011 ] - Market Wire
Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
[ Tue, Nov 29th 2011 ] - Market Wire
Natural Alternatives International, Inc. Announce .. Beta-Alanine Patent Protecting CarnoSyn Products
[ Tue, Nov 29th 2011 ] - Market Wire
Soliris (eculizumab) riceve l'autorizzazione alla .. a per il trattamento dei pazienti affetti da sind
[ Tue, Nov 29th 2011 ] - Market Wire
NeuroMetrix to Present at Canaccord Genuity 6th A .. ular, Aesthetics & Metabolic Disorders Conference
[ Tue, Nov 29th 2011 ] - Market Wire
Extraordinary general meeting of shareholders of Basilea Pharmaceutica Ltd.
[ Tue, Nov 29th 2011 ] - Market Wire
TheraBiogen, Inc. Launches National Radio Ad Campaign
[ Tue, Nov 29th 2011 ] - Market Wire
Medicure Reports First Quarter 2012 Financial Results
[ Tue, Nov 29th 2011 ] - Market Wire
Gilead krijgt Europese vergunning voor het in de .. een nieuw, compleet eenmaal daags enkel-tablet r
[ Tue, Nov 29th 2011 ] - Market Wire
Vergunning verleend voor het in de handel brengen .. Europa ter behandeling van patinten met atypisch
[ Tue, Nov 29th 2011 ] - Market Wire
Soliris (eculizumab) obtiene autorizacin para com .. l tratamiento de pacientes con sndrome urmico hem
[ Tue, Nov 29th 2011 ] - Market Wire
Humana Announces Agreement to Acquire SeniorBridge
[ Tue, Nov 29th 2011 ] - Market Wire
Gilead obtiene autorizacin de comercializacin en .. vo rgimen de nica pastilla, una vez al da para la
[ Tue, Nov 29th 2011 ] - Market Wire
Cubist Pharmaceuticals to Present at December 2011 Investor Conferences

Cubist Pharmaceuticals to Present at December 2011 Investor Conferences


Published on 2011-11-29 08:06:32 - Market Wire
  Print publication without navigation


LEXINGTON, Mass.--([ ])--[ Cubist Pharmaceuticals, Inc. ] (NASDAQ: CBST) today announced that company management will present at investor conferences during December 2011 to discuss the companyas business activities, financial outlook, and current news.

  • David McGirr, SVP and CFO, will present on Tuesday, December 6, at 8:30 a.m. (GMT), at the NASDAQ OMX 27th Investor Program being held at The Chancery Court Hotel in London. ([ Live audio with slides webcast ])
  • Michael Bonney, President and CEO, will host one-on-one meetings on Thursday, December 15, at the Bank of America Merrill Lynch 2011 Denver Healthcare Conference being held at The J.W. Marriott Hotel at Cherry Creek in Denver.

The live webcast will be accessible through Cubistas [ website ] in the Investor Relations Conference Calendar section and will be available for viewing at that location for 30 days after the presentation.

About Cubist

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubistas [ website ].

Contributing Sources